
Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Timothy Busfield turns himself in to face child sexual abuse charges in New Mexico - 2
Why home maintenance deserves a spot in the annual health and budget plans - 3
In the background: Visiting Notable Film Areas All over the Planet - 4
The Reduced Portage Horse: An Inheritance Reconsidered for Present day Experience - 5
The 10 Most Famous Works of art Ever
You finally got a doctor's appointment. Here's how to get the most out of it
Story of ‘first Black Briton’ rewritten by advances in ancient DNA technology
'Malcolm in the Middle' reboot releases 1st trailer, reuniting Frankie Muniz and Bryan Cranston: Watch here
Vice President Dick Cheney’s life followed the arc of the biggest breakthroughs in cardiovascular medicine
A definitive Manual for the Over-Ear Earphones
Instructions to Upgrade the Mechanical Highlights of Your Shrewd Bed for a Superior Night's Rest
Favored Organic product for Seniors' Prosperity: Make Your Determination
6 Famous Urban communities for Shopping on the planet
Step by step instructions to Guarantee Your Internet Promoting Degree Supplements Your Profession Objectives












